dopamine + furosemide

Dopamine + furosemide is a combination therapy involving the intravenous administration of dopamine, a catecholamine vasopressor and inotrope, with furosemide, a loop diuretic. This combination is primarily used in clinical settings for patients with acute decompensated heart failure or hepatorenal syndrome to enhance diuresis and improve cardiac function. Dopamine acts as an agonist at dopaminergic and adrenergic receptors to increase renal blood flow (at low doses) and support cardiac output (at higher doses), while furosemide inhibits the Na-K-2Cl symporter in the thick ascending limb of the loop of Henle, promoting natriuresis and diuresis. The combined use aims to maximize fluid removal while supporting renal perfusion and minimizing adverse effects such as electrolyte imbalance or hypotension[1][4][5]. Clinical studies suggest this regimen can be more effective than monotherapy with either agent for certain patient populations[1][4][5].

Other names

dopamine and furosemidedopamine plus furosemide